$PVSP (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: P
Post# of 35498
(Total Views: 185)
Posted On: 06/28/2022 9:20:05 AM
$PVSP (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, and Artizen Corp. (“Artizen”) today announced that it and Dr. Kyeung-Il Park, the Head of Department of Horticulture & Life Science in Yeungnam University, in partnership with KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: QENC) (“KRTL”), have received approval to be acting as the exclusive expert groups providing services and support for the development of the indoor smart growing section of the Korean Hemp development project.
Pervasip is pleased to announce that it, and Dr. Kyeung-Il Park, a KRTL Biotech Inc. team member, have received an agreement by the Hemp Regulation Free Special Zone Project Promotion Team in Kyeongbuk Institute for Bio Industry, a local public enterprise, (http://gib.re.kr/about/major/major2), and both KRTL International Corp., and Artizen Corporation have been hired by Dr. Kyeung-il Park to act as exclusive consulting groups to provide services and support for the development of indoor smart growing, one of three core strategic areas of interest in development for the Korean CBD industry regulations sector.
Korea has committed $40 million to assist in the development of this emerging industry. They are funding various greenhouse trials, research, policy development and testing efforts.
“We are excited about the opportunity to work with KRTL on this project. It allows us to become trusted partners in what will become a true center of excellence for developing CBD/Hemp opportunities throughout Asia,” says German Burtscher, the company’s President & CEO. “We look at this as another step in supporting our development of market disrupting wellness products and distribution.”
KRTL International Corp’s CEO Kai Kim has developed a potent network of government institutions, universities, research labs, companies, and individual experts in his work on developing CBD related efforts in S. Korea over the past 6 years.
Pervasip is pleased to announce that it, and Dr. Kyeung-Il Park, a KRTL Biotech Inc. team member, have received an agreement by the Hemp Regulation Free Special Zone Project Promotion Team in Kyeongbuk Institute for Bio Industry, a local public enterprise, (http://gib.re.kr/about/major/major2), and both KRTL International Corp., and Artizen Corporation have been hired by Dr. Kyeung-il Park to act as exclusive consulting groups to provide services and support for the development of indoor smart growing, one of three core strategic areas of interest in development for the Korean CBD industry regulations sector.
Korea has committed $40 million to assist in the development of this emerging industry. They are funding various greenhouse trials, research, policy development and testing efforts.
“We are excited about the opportunity to work with KRTL on this project. It allows us to become trusted partners in what will become a true center of excellence for developing CBD/Hemp opportunities throughout Asia,” says German Burtscher, the company’s President & CEO. “We look at this as another step in supporting our development of market disrupting wellness products and distribution.”
KRTL International Corp’s CEO Kai Kim has developed a potent network of government institutions, universities, research labs, companies, and individual experts in his work on developing CBD related efforts in S. Korea over the past 6 years.
(0)
(0)Scroll down for more posts ▼